RXO logo

RXO Inc. (RXO)

$28.68

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on RXO

Market cap

$4.73B

EPS

-0.52

P/E ratio

--

Price to sales

0.79

Dividend yield

--

Beta

1.84838

Price on RXO

Previous close

$28.35

Today's open

$28.19

Day's range

$28.19 - $28.74

52 week range

$10.43 - $29.90

Profile about RXO

CEO

Drew Wilkerson

Employees

6906

Headquarters

Charlotte, NC

Exchange

New York Stock Exchange

Shares outstanding

164951056

Issue type

Common Stock

RXO industries and sectors

Industrials

Transportation

News on RXO

RXO Q3 Earnings & Revenues Beat Estimates on Brokerage Strength

RXO's Q3 2026 earnings surge 800% as revenues rise 31.7%, driven by brokerage strength and higher freight rates, despite margin pressure and rising costs.

news source

Zacks Investment Research • 2 hours ago

news preview

RXO's Latest Curve Freight Market Forecast Marks the Tenth Consecutive Quarter of Spot Rate Inflation

CHARLOTTE, N.C.--(BUSINESS WIRE)---- $RXO #nyse--RXO (NYSE: RXO), a leading provider of asset-light transportation solutions, today released the latest update to its proprietary Curve truckload market forecast, which shows strong year-over-year spot rate growth, excluding the impacts of fuel. In the third quarter, spot rates, as measured by the Curve, started off strong in July. Though rates moderated in August and September, the index still finished the quarter at 37.9%, its highest level since 2021 and an i.

news source

Business Wire • Nov 17, 2026

news preview

C.H. Robinson Worldwide Targets $300 Million in RXO Savings as Freight Costs Rise

C.H. Robinson Worldwide NASDAQ: CHRW executives said the freight broker plans to continue investing in organic growth while pursuing its RXO acquisition, with Chief Financial Officer Damon Lee pointing to anticipated cost savings and reduced debt as key benefits of the deal.

news source

MarketBeat • Nov 14, 2026

news preview

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: ADT Inc. (NYSE – ADT), RXO Inc. (NYSE – RXO), PTC Inc. (Nasdaq – PTC), Lifecore Biomedical, Inc. (Nasdaq – LFCR)

BALA CYNWYD, Pa., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

news source

GlobeNewsWire • Nov 11, 2026

news preview

INVESTIGATION ALERT - The M&A Class Action Firm Is Investigating the Merger – OPCH, PTC, RXO and SYNA - IS IT A FAIR DEAL FOR YOU?

NEW YORK, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney  Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. We are headquartered on the 47th floor in the Empire State Building in New York City and are investigating if below deal is fair:

news source

GlobeNewsWire • Nov 4, 2026

news preview

RXO Delivers Strong Third-Quarter Results with Profitable Growth and Continued Market Share Gains

CHARLOTTE, N.C.--(BUSINESS WIRE)---- $RXO #nyse--RXO (NYSE: RXO) today reported strong third-quarter financial results. RXO Chairman and CEO Drew Wilkerson said, “We exceeded the high end of our third-quarter profit outlook, demonstrating the momentum we're building across RXO. We continued to take market share in Brokerage, and achieved a 3 percent increase in truckload volume, outperforming the market. We achieved a 900 basis-point sequential increase in truckload spot mix, which helped drive the best seque.

news source

Business Wire • Oct 29, 2026

news preview

RXO (RXO) Q3 Earnings and Revenues Top Estimates

RXO (RXO) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.01 per share a year ago.

news source

Zacks Investment Research • Oct 29, 2026

news preview

RXO (RXO) Reports Q3 Earnings: What Key Metrics Have to Say

The headline numbers for RXO (RXO) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

news source

Zacks Investment Research • Oct 29, 2026

news preview

Despite Fast-paced Momentum, RXO (RXO) Is Still a Bargain Stock

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, RXO (RXO) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

news source

Zacks Investment Research • Oct 22, 2026

news preview

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Silence Therapeutics plc (Nasdaq – SLN), Option Care Health, Inc. (Nasdaq – OPCH), RXO Inc. (NYSE – RXO), Sangoma Technologies Corporation (Nasdaq – SANG)

BALA CYNWYD, Pa., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

news source

GlobeNewsWire • Oct 20, 2026

news preview

¹ Disclosures

Get started with M1

Invest in RXO Inc.

Open an M1 investment account to buy and sell RXO Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in RXO on M1